Stay updated on Risankizumab in PsA Patients: Clinical Trial
Sign up to get notified when there's something new on the Risankizumab in PsA Patients: Clinical Trial page.

Latest updates to the Risankizumab in PsA Patients: Clinical Trial page
- Check3 days agoChange DetectedThe page now displays a 403 Forbidden error and the Study Documents section has been removed, leaving only the basic header and footer with no downloadable documents.SummaryDifference18%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA Funding line '2017 ( U.S. NIH Grant/Contract )' was added to the study details, and the page revision tag was updated from v3.6.5 to v3.6.6.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision tag updated to v3.6.5, replacing the previous v3.6.4. This change reflects a deployment update to the page rather than modification to study data.SummaryDifference0.0%

- Check53 days agoChange DetectedThe Ukraine site entry was updated from Zaporizhzhia to Zaporizhzhya in the locations list, reflecting a transliteration/name update for the city.SummaryDifference0.0%

- Check60 days agoChange DetectedThe footer revision changed from Revision: v3.6.3 to Revision: v3.6.4. This appears to be a general site update with no change to the study details or user actions.SummaryDifference0.0%

- Check82 days agoChange DetectedThe page revision label was updated from v3.6.2 to v3.6.3, indicating a small update to the page's documentation/history.SummaryDifference0.0%

Stay in the know with updates to Risankizumab in PsA Patients: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab in PsA Patients: Clinical Trial page.